ETF · Cboe BZX: HELX
HELX — Franklin Genomic Advancements ETF
Franklin Genomic Advancements ETF (HELX) is an exchange-traded fund listed on Cboe BZX. On Bright Analyst you can analyze HELX's holdings, sector allocation, performance, expense ratio, dividends and similar ETFs, alongside an AI-written fund analysis.
Key facts
- Ticker symbol
- HELX
- Exchange
- Cboe BZX
- ISIN
- US35473P5200
- Security type
- Exchange-traded fund
Research HELX
- Price Chart — Interactive price history with AI commentary.
- Fund Analysis — Fund profile, strategy, index and an AI-written analysis.
- Performance — Returns, valuation and expense ratio against its category.
- Holdings — Every position with its weight, sector and asset type.
- Allocation — Sector, asset-class and top-holding concentration.
- Peers — Comparison with similar ETFs on cost, returns and holdings.
- Dividends — Dividend yield and distribution history.
- News — Latest headlines about the fund and its issuer.
Frequently asked questions
What is the HELX ETF?
HELX is the ticker symbol of Franklin Genomic Advancements ETF, an exchange-traded fund listed on Cboe BZX with ISIN US35473P5200.
What does HELX hold?
The HELX Holdings page lists every position in Franklin Genomic Advancements ETF with its portfolio weight, and the Allocation page breaks the fund down by sector and asset class.
Does HELX pay a dividend?
The HELX Dividends page shows the fund's dividend yield and distribution history for any period in which it has paid distributions.
What are alternatives to HELX?
The HELX Peers page compares Franklin Genomic Advancements ETF with similar ETFs on cost, performance and holdings.
For information only — not investment advice.